The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema, in the attached consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 27th March 2024. Take part by visiting the consultations page.